ProtoKinetix Inc (PKTX)

[drugmanrx]

http://www.ipindia.nic.in/writereaddata/Portal/IPOJournal/1_459_1/part1.pdf

4/14/2017 page 314

1)
Name of Applicant :
1)PROTOKINETIX INC.
Address of Applicant :9176 South Pleasants Highway St.
Marys West Virginia 26170 U.S.A.
(72)
Name of Inventor :
1)YOUNG Lachlan Grant
2)SHAPIRO A. M. James

Plus the April 2017 newsletter is back at the Bachem site,


CHEMICAL GLYCOSYLATION IN CLINICAL DEVELOPMENT

PKX001--Insulin-Dependent Diabetes Mellitus(I) Dermatology(PC) Inflammatory Disorders(PC)

Phase I ProtoKinetix Inc, University of Alberta

http://www.bachem.com/service-support/newsletter

PKX001 is an anti-aging glycopeptide being developed by ProtoKinetix for the treatment of inflammation, non-insulin dependent diabetes and skin disorders. In March 2017, ProtoKinetix announced that the company started a Phase I clinical trial of PKX-001 treated islet cells used in conjunction with the Edmonton Protocol for the treatment of Type 1 diabetes (3).